- Home
- HERZ vs PLSM Comparison
HERZ vs PLSM Comparison
Compare HERZ & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HERZ | PLSM |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | Israel |
| Employees | N/A | 63 |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.7M | 22.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HERZ | PLSM |
|---|---|---|
| Price | $18.73 | $4.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.8K | ★ 33.8K |
| Earning Date | N/A | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.62 | $3.00 |
| 52 Week High | $19.30 | $7.15 |
Technical Indicators
Market Signals| Indicator | HERZ | PLSM |
|---|---|---|
| Relative Strength Index (RSI) | 51.73 | 58.65 |
| Support Level | $17.42 | $3.49 |
| Resistance Level | $19.08 | $5.00 |
| Average True Range (ATR) | 0.78 | 0.69 |
| MACD | -0.05 | 0.06 |
| Stochastic Oscillator | 41.91 | 34.90 |
Price Performance
Historical ComparisonAbout HERZ Herzfeld Credit Income Fund Inc.
Herzfeld Credit Income Fund Inc is a non-diversified, closed-end management investment company. Its primary investment objective is to maximize risk-adjusted total returns, and its secondary investment objective is to generate high current income.
About PLSM Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.